SavedAdd your journal

Journals / Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi / 2020 / Cilt: 10 - Sayı: 2

Management of HIV Infection during Pregnancy by Gynecologist and Obstetricians

Kadın Hastalıkları ve Doğum Hekimlerinin HIV (+) Gebe Yönetimindeki Bilgi, Tutum ve Davranışlarının İncelenmesi

Mustafa ALTINDİŞ
Oğuz KARABAY
Hande TOPTAN
Hilal USLU YUVACI
Tuğba KAYA
Serhan. CEVRİOĞLU
Pages
223–227
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For HIV(+) maternal delivery type, 35 (28%) of those who stated that cesarean section had no advantage in terms of transmission in the pregnant with a viral load

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, it was aimed to investigate the knowledge, attitudes and behaviors of gynecologists and obstetricians (G/O) during pregnant management in terms of HIV.
📊
Key Findings & Data:Results: Of the total 125 participants, 52 (41.6%) were male, 86 (68.8%) were specialist physicians, 13 (10.4%) were research assistants, 34 (27.2%) had 20 years or more professional experience, 115 (92%) of the pregnant women regularly ask for anti-HIV tests, 77 (61.6%) of them had anti-HIV positive pregnant patients at least once, 49 (39.2%) have followed anti-HIV positive pregnant women so far, 51 (40.8%) had given birth to at least one anti-HIV positive pregnant woman. 19 (15.2%) of the physicians didn’t give information to HIV positive mothers not to breastfeed. 79 (63.2%) of those who know that IV zidovudine administration in an HIV positive pregnant with HIVRNA levels> 1000 copies/mL and 55 (44%) of those who use zidovudine for six weeks for prophylaxis.
💡
Conclusion & Impact:For HIV(+) maternal delivery type, 35 (28%) of those who stated that cesarean section had no advantage in terms of transmission in the pregnant with a viral load
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: In this study, it was aimed to investigate the knowledge, attitudes and behaviors of gynecologists and obstetricians (G/O) during pregnant management in terms of HIV. Material and Methods: Online questionnaire was reached to G/O physicians to determine relevant knowledge about HIV (+) pregnant management. Information was evaluated by MS Excel. Results: Of the total 125 participants, 52 (41.6%) were male, 86 (68.8%) were specialist physicians, 13 (10.4%) were research assistants, 34 (27.2%) had 20 years or more professional experience, 115 (92%) of the pregnant women regularly ask for anti-HIV tests, 77 (61.6%) of them had anti-HIV positive pregnant patients at least once, 49 (39.2%) have followed anti-HIV positive pregnant women so far, 51 (40.8%) had given birth to at least one anti-HIV positive pregnant woman. 19 (15.2%) of the physicians didn’t give information to HIV positive mothers not to breastfeed. 79 (63.2%) of those who know that IV zidovudine administration in an HIV positive pregnant with HIVRNA levels> 1000 copies/mL and 55 (44%) of those who use zidovudine for six weeks for prophylaxis. For HIV(+) maternal delivery type, 35 (28%) of those who stated that cesarean section had no advantage in terms of transmission in the pregnant with a viral load

Özet

Amaç: HIV (Human Immunodeficiency Virus) (+) gebe yönetiminde, tarama testleri ve viral yük incelemeleri, etkiliantiretroviral tedavi, sezaryen ile doğum ve emzirmeden kaçınma en güncel konulardır. Bu çalışmada kadın hastalıklarıve doğum (KD) hekimlerinin HIV (+) gebe yönetimi konusundaki bilgi, tutum ve davranışlarının incelenmesiamaçlanmıştır.Gereç ve Yöntemler: Demografik bilgiler ve literatürden destek alınarak HIV (+) gebe yönetimine yönelik hazırlananonline/dijital anket ile KD hekimlerine ulaşılarak konu ile alakalı bilgi, tutum ve davranışları belirlenmeye çalışıldı.Bulgular: Toplam 125 katılımcının 52’si (%41,6) erkek, 86’sı (%68,8) uzman hekim, 13’ü (%10,4) araştırma görevlisi,34’ü (%27,2) 20 yıl ve üzeri mesleki deneyime sahip, 115’i (%92) gebelerden düzenli olarak Anti-HIV testi istemekteolup 77’sinin (%61,6) en az bir kez Anti-HIV pozitif gebe hastası olmuş, 49’u (%39,2) bugüne kadar Anti-HIV pozitifgebe takibi yapmış, 51’i (%40,8) ise Anti-HIV pozitif en az bir gebeye doğum yaptırmıştı. Hekimlerin 121’i (%96,8)Anti-HIV pozitif gebeleri doğrulama testlerine yönlendirirken 19’u (%15,2) Anti-HIV pozitif anneye emzirmemesikonusunda bilgi vermediğini belirtti. Doğum sırasında HIV RNA düzeyleri >1000 kopya/mL veya viral yükübilinmeyen Anti-HIV pozitif gebede IV zidovudin uygulanmasının bebeğe bulaş riskini azalttığını bilenler 79 (%63,2)iken HIV (+) anneden doğana profilaksi amaçlı altı hafta zidovudin kullananlar 55’tir (%44). Anti-HIV (+) annenindoğum şekli için “Viral yükü

🔖

Cite This Article

ALTINDİŞ, M., KARABAY, O., TOPTAN, H., YUVACI, H. U., KAYA, T., CEVRİOĞLU, S. (2022). Management of HIV Infection during Pregnancy by Gynecologist and Obstetricians. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, Cilt: 10 - Sayı: 2, 223–227. https://ajindex.com/articles/649853

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Jaffar S, Grant AD, Whitworth J, Smith PG, Whittle H. The natural history of HIV–1 and HIV–2 infections in adults in Africa: a literature review. Bull World Health Organ. 2004; 82(6): 462-9
  2. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science. 1994; 265(5178): 1587-90
  3. Who.int [internet]. HIV/AIDS Data and Statistics [Cited: 25.11.2019]. Available from:
  4. Kenyon C. Colebunders R. Voeten H. Lurie M. Peak HIV prevalence: a useful outcome variable for ecological studies. Int J Infect Dis. 2013; 17(5): e286- 8
  5. Unaids.org [internet]. Children and HIV Fact sheet [Cited: 25.11.2019]. Available from: https://www.unaids.org/sites/default/files/media_asset /FactSheet_Children_en.pdf
  6. Unaids.org [internet]. UNAIDS 2017 [Cited:25.11.2019]. Available from: https://www.unaids.org/sites/default/files/media_asset /20170720_Data_book_2017_en.pdf
  7. Haas AD, Msukwa MT, Egger M, Tenthani L, Tweya H, Jahn A, et al. Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving care in Malawi's option B+ program. Clin Infect Dis. 2016; 63(9): 1227-35
  8. Platten M, Pham HN, Nguyen HV, Nguyen NT, Le GM. Knowledge of HIV and factors associated with attitudes towards HIV among final-year medical students at Hanoi medical university in Vietnam. BMC Public Health. 2014; 14: 265
  9. Hsgm.saglık.gov.tr [internet]. Türkiye HIV/AIDS Kontrol Programı [Erişim tarihi: 29.11.2019]. Erişim adresi: https://hsgm.saglik.gov.tr/tr/bulasicihastaliklar/hiv-aids/hiv-aids-liste/hiv-aids-tani-tedavirehberi.html. 10.Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents and pregnant women in health-care settings. Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep. 2006; 55(14): 1-17
  10. Gray AD, Carlson R, Morgan M, Hawks D, Schulkin J. Obstetrician-gynecologists’ knowledge and practice regarding human immunodeficiency virus screening. Obstet Gynecol. 2007; 110(5): 1019-26
  11. McKinney MM, McSpirit S, Pomeroy C. Prenatal HIV prevention practices in a low seroprevalence state. AIDS Educ Prev. 2000; 12(3): 252-62
  12. Olges JR, Murphy BS, Caldwell GG. Thornton AC. Testing practices and knowledge of HIV among prenatal care providers in a low seroprevalence state. AIDS Patient Care STDS. 2007; 21(3): 187-94
  13. Quach L, Ma